HighTower Advisors’s Alpha Tau Medical DRTS Stock Holding History

HighTower Advisors’s Portfolio DRTS Stock Details DRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.19M	Buy	874,994 +188,440	+27%	+$1.33M	0.01%	1094
2025 Q4	$3.4M	Hold	686,554	–	–	﹤0.01%	1373
2025 Q3	$3.1M	Hold	686,554	–	–	﹤0.01%	1388
2025 Q2	$2.14M	Buy	686,554 +455,850	+198%	+$1.28M	﹤0.01%	1526
2025 Q1	$579K	Hold	230,704	–	–	﹤0.01%	2336
2024 Q4	$715K	Hold	230,704	–	–	﹤0.01%	2204
2024 Q3	$549K	Hold	230,704	–	–	﹤0.01%	2332
2024 Q2	$584K	Buy	230,704 +18,196	+9%	+$46.3K	﹤0.01%	2209
2024 Q1	$627K	Hold	212,508	–	–	﹤0.01%	2113
2023 Q4	$639K	Buy	+212,508	New	+$684K	﹤0.01%	2146

Other funds holding DRTS

Aquamarine Financial George Town $1.37B AUM

Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return

DSC

Daytona Street Capital Saint Louis, Missouri $130M AUM

Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

GIA

Gem Investment Advisors Teaneck, New Jersey $102M AUM

LCS

Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

HighTower Advisors's DRTS Position: Q1 2026 in Review

HighTower Advisors increased its Alpha Tau Medical (DRTS) stake by 27% in Q1 2026, buying an estimated $1.33M and bringing the position to 874,994 shares worth $6.19M. The position accounts for 0.01% of the portfolio, ranked #1094.

HighTower Advisors first reported a position in DRTS in Q4 2023 and has held it in 10 quarters since. 53 funds tracked by Wall St. Rank hold DRTS as of Q1 2026.

HighTower Advisors held 874,994 shares of Alpha Tau Medical worth $6.19M as of Q1 2026.
HighTower Advisors bought 188,440 Alpha Tau Medical shares in Q1 2026, an estimated $1.33M.
Alpha Tau Medical made up 0.01% of HighTower Advisors's portfolio in Q1 2026, its #1094 holding.
HighTower Advisors first reported a position in Alpha Tau Medical in Q4 2023 and has held it in 10 quarters since.
53 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.